Spangler Patrick D 4
4 · OptimizeRx Corp · Filed Nov 15, 2021
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Spangler Patrick D
Director
Transactions
- Sale
Common Stock (pursuant to 10B5-1 plan)
2021-11-11$84.38/sh−6,252$527,544→ 16,083 total
Footnotes (1)
- [F1]These shares sold pursuant to a plan of disposition adopted on September 7, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.